Michael Manz
Antithrombotic therapy and assessment for bleeding diathesis in elective gastrointestinal endoscopy - Expert Opinion Statement on behalf of the Swiss Society of Gastroenterology.
Wiegand N, Geyer M, Lollo G, Wuillemin W, Aepli P, Frei R, Godat S, Manz M, Seewald S, The F, Wiest R, Borovicka J, Brand S, Buyse S, Degen L, Ehmann T, Riniker F, Riva D, Semela D, Truninger K, Utzinger E, Vonlaufen A. Antithrombotic therapy and assessment for bleeding diathesis in elective gastrointestinal endoscopy - Expert Opinion Statement on behalf of the Swiss Society of Gastroenterology. Praxis (Bern 1994) 2023; 112:635-641.
Dec 1, 2023Antithrombotic therapy and assessment for bleeding diathesis in elective gastrointestinal endoscopy - Expert Opinion Statement on behalf of the Swiss Society of Gastroenterology.
Dec 1, 2023Praxis (Bern 1994) 2023; 112:635-641
Wiegand Nico, Geyer Martin, Lollo Gianluca, Wuillemin W A, Aepli Patrick, Frei Remus, Godat Sébastien, Manz Michael, Seewald Stefan, The Frans Olivier, Wiest Reiner, Borovicka Jan, Brand Stephan, Buyse Sophie, Degen Lukas, Ehmann Tobias, Riniker Florian, Riva Daniele, Semela David, Truninger Kaspar, Utzinger Ellen, Vonlaufen Alain
Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists
Vavricka S, Rogler G, Safroneeva E, Peter S, Beglinger C, Biedermann L, Manz M, Rechner R, Degen L, Sulz M, Schoepfer A. Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists. Endoscopy 2016
Jan 25, 2016Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the performance of endoscopists
Jan 25, 2016Endoscopy 2016
Vavricka Stephan R, Rogler Gerhard, Safroneeva Ekaterina, Peter Shajan, Beglinger Christoph, Biedermann Luc, Manz Michael, Rechner Roman, Degen Lukas, Sulz Michael, Schoepfer Alain M
Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey
Vavricka S, Michetti P, Straumann A, Seibold F, Scharl M, Sauter B, de Saussure P, Rogler G, Manz M, Geyer M, Felley C, Binek J, Bansky G, Schoepfer A, for the Swiss IBDnet. Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey. Inflamm Bowel Dis 2010
Dec 22, 2010Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey
Dec 22, 2010Inflamm Bowel Dis 2010
Vavricka Stephan R, Michetti Pierre, Straumann Alex, Seibold Frank, Scharl Michael, Sauter Bernhard, de Saussure Philippe, Rogler Gerhard, Manz Michael, Geyer Martin, Felley Christian, Binek Janek, Bansky Georg, Schoepfer Alain M, for the Swiss IBDnet
Natürliche Chromoendoskopie
Sawatzki M, Beglinger C, Lugli A, Manz M. Natürliche Chromoendoskopie. Schweiz Med Forum 2010; 10:139.
Jan 1, 2010Natürliche Chromoendoskopie
Jan 1, 2010Schweiz Med Forum 2010; 10:139
Sawatzki Mikael, Beglinger Christoph, Lugli Alessandro, Manz Michael
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey
Schoepfer A, Straumann A, Seibold F, Sauter B, de Saussure P, Rogler G, Manz M, Geyer M, Felley C, Binek J, Vavricka S, Michetti P. Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey. Inflammatory bowel diseases 2009
Dec 10, 2009Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey
Dec 10, 2009Inflammatory bowel diseases 2009
Schoepfer Alain M, Straumann Alex, Seibold Frank, Sauter Bernhard, de Saussure Philippe, Rogler Gerhard, Manz Michael, Geyer Martin, Felley Christian, Binek Janek, Vavricka Stephan R, Michetti Pierre